chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 55.0
Sex: F
Vaccine: FLU4
Symptoms: X-ray normal
Clinical narrative: This spontaneous case, reported by non-health care professional (other) to VAERS and initially retrieved on 21-Feb-2018 by Seqirus from VAERS (VAERS ID: 728698), concerns a 55-year-old, adult, female patient. The patient had no medical history and no allergies. The patient's concomitant medication included Vitamins for an unknown indication (on an unspecified date). On 10-Oct-2017, the patient was administered with AFLURIA QUADRIVALENT (dose: 0.5 ml, route of administration: injection, anatomical location: left arm, batch number and expiry date: not reported). On the same day, the patient received flu shot on extremely high on the arm, almost on the shoulder, which lead to severe shoulder pain and treated with Prednisone for 5 days (on an unspecified date). At night, the patient had high fever, aches and chills. On the same day, the patient still had a lot of pain and went to physician and received ZITHROMAX Z-PACK 6 days for an unknown indication. It was reported that, after 2.5 weeks, the patient still had severe pain. On unspecified date, 2.5 weeks ago, X-ray was performed, which showed no injury and result reported as normal. At the time of the report, the patient had not recovered from the events (chills, shoulder pain, ache and fever). The reporter assessed the case as non-serious.
Age: 65.0
Sex: F
Vaccine: FLU4
Symptoms: Blepharospasm
Clinical narrative: This is a spontaneous case, reported by other healthcare professional to VAERS and initially retrieved on 21-Feb-2018 by Seqirus from VAERS (VAERS ID: 728703), concerns a 65-year-old, elderly, female patient. The patient had no historical or current conditions. The patient's concomitant medications included TUMS, estradiol, Multivitamin, sodium chloride and timolol for an unknown indication. The patient had been allergic to ibuprofen, erythromycin, aspirin, omeprazole, CEFTIN, BENADRYL and PRILOSEC. On 19-Oct-2017, the patient was administered with AFLURIA QUADRIVALENT (dose: 0.5 ml, route of administration: intramuscular, anatomical location: left arm, batch number: XF30506 and expiry date: not reported). On 20-Oct-2017, after 1 day of vaccination, the patient experienced blepharospasm. No lab investigation was done. On an unspecified date, the patient had recovered from the event. The reporter assessed the event as non-serious. Non-significant case correction received with IRD 21-Feb-2018: The statement "The patient is receiving Timolol as concomitant medication, indicated for underlying ocular pathological condition" was removed from the case comment.
Sex: F
Vaccine: FLU4
Symptoms: Injection site pain, Injection site rash, Injection site warmth, Joint range of motion measurement, Laboratory test
Clinical narrative: This spontaneous case, reported by health care professional (other) to VAERS and initially retrieved on 21-Feb-2018 by Seqirus from VAERS (VAERS ID: 728239), concerns a 29-year-old, adult, female patient. The patient's historical condition included back problems and current condition included allergy to penicillin (PCN as reported). The concomitant medication included MONONESSA for an unknown indication (on an unspecified date). On 21-Nov-2017, the patient was administered with AFLURIA QUADRIVALENT (dose: 0.5 ml, route of administration: intramuscular, anatomical location: left arm, batch number: XF34709 and expiry date: not reported). On the same day, after vaccination, the patient was afebrile and had left shoulder pain with handball size rash, which was warm and pain to touch. It was reported that, the patient had left arm weakness and shooting pain from armpit to elbow and fingers 2-5 with tingling. The patient was treated with antibiotics. On the same day, Phalen's test was performed and result was reported as positive. On an unspecified date, sensory level test, tinel tests and range of motion (ROM) tests were performed and results reported as normal. The muscle strength test with equal bilaterally was performed and found as possibly 4-5/5 (as reported) on left. At the time of the report, the patient had not recovered from the events (weakness of arms, injection site warmth, shooting pain, tingling, injection site pain, Phalen's test positive, injection site pain and injection site rash). The reporter assessed the case as non-serious. Significant case correction received with IRD 21-Feb-2018: Listedness for the event paraesthesia was changed from unlisted to listed for both flu vaccine egg split CSL and flu vaccine egg split CSL.
Sex: F
Vaccine: FLU4
Symptoms: Muscular weakness, Pain, Pain in extremity, Paraesthesia, Phalen's test positive
Clinical narrative: This spontaneous case, reported by health care professional (other) to VAERS and initially retrieved on 21-Feb-2018 by Seqirus from VAERS (VAERS ID: 728239), concerns a 29-year-old, adult, female patient. The patient's historical condition included back problems and current condition included allergy to penicillin (PCN as reported). The concomitant medication included MONONESSA for an unknown indication (on an unspecified date). On 21-Nov-2017, the patient was administered with AFLURIA QUADRIVALENT (dose: 0.5 ml, route of administration: intramuscular, anatomical location: left arm, batch number: XF34709 and expiry date: not reported). On the same day, after vaccination, the patient was afebrile and had left shoulder pain with handball size rash, which was warm and pain to touch. It was reported that, the patient had left arm weakness and shooting pain from armpit to elbow and fingers 2-5 with tingling. The patient was treated with antibiotics. On the same day, Phalen's test was performed and result was reported as positive. On an unspecified date, sensory level test, tinel tests and range of motion (ROM) tests were performed and results reported as normal. The muscle strength test with equal bilaterally was performed and found as possibly 4-5/5 (as reported) on left. At the time of the report, the patient had not recovered from the events (weakness of arms, injection site warmth, shooting pain, tingling, injection site pain, Phalen's test positive, injection site pain and injection site rash). The reporter assessed the case as non-serious. Significant case correction received with IRD 21-Feb-2018: Listedness for the event paraesthesia was changed from unlisted to listed for both flu vaccine egg split CSL and flu vaccine egg split CSL.
Sex: F
Vaccine: FLU4
Symptoms: Sensory level normal
Clinical narrative: This spontaneous case, reported by health care professional (other) to VAERS and initially retrieved on 21-Feb-2018 by Seqirus from VAERS (VAERS ID: 728239), concerns a 29-year-old, adult, female patient. The patient's historical condition included back problems and current condition included allergy to penicillin (PCN as reported). The concomitant medication included MONONESSA for an unknown indication (on an unspecified date). On 21-Nov-2017, the patient was administered with AFLURIA QUADRIVALENT (dose: 0.5 ml, route of administration: intramuscular, anatomical location: left arm, batch number: XF34709 and expiry date: not reported). On the same day, after vaccination, the patient was afebrile and had left shoulder pain with handball size rash, which was warm and pain to touch. It was reported that, the patient had left arm weakness and shooting pain from armpit to elbow and fingers 2-5 with tingling. The patient was treated with antibiotics. On the same day, Phalen's test was performed and result was reported as positive. On an unspecified date, sensory level test, tinel tests and range of motion (ROM) tests were performed and results reported as normal. The muscle strength test with equal bilaterally was performed and found as possibly 4-5/5 (as reported) on left. At the time of the report, the patient had not recovered from the events (weakness of arms, injection site warmth, shooting pain, tingling, injection site pain, Phalen's test positive, injection site pain and injection site rash). The reporter assessed the case as non-serious. Significant case correction received with IRD 21-Feb-2018: Listedness for the event paraesthesia was changed from unlisted to listed for both flu vaccine egg split CSL and flu vaccine egg split CSL.
Sex: F
Vaccine: FLU4
Symptoms: Dizziness, Headache
Clinical narrative: This spontaneous case, reported by healthcare professional to VAERS and initially retrieved on 21-Feb-2018 by Seqirus from VAERS (VAERS ID: 728774), concerns a 51-year-old, adult female patient. The patient's current condition included menopause and diabetes since an unspecified date. The patient's concomitant medication included carmellose, SOLOSTAR, ketotifen fumarate, metformin hydrochloride, NYSTATIN and aspirin for unknown indication. On 27-Oct-2017, the patient was vaccinated with AFLURIA QUADRIVALENT (dose: 0.5 ml (reported as 1), route of administration: intramuscular, anatomical location: left arm, batch number: XF34909 and expiry date: not reported). On the same day (27-Nov-2017), 02 hrs after vaccination, the patient experienced dizziness and headache. Reportedly, the patient was treated with unspecified fluids. At the time of this report, the patient had not recovered from the events. The reporter assessed this report as non-serious.
Age: 37.0
Sex: F
Vaccine: FLU4
Symptoms: Burning sensation, Immediate post-injection reaction, Irritability, Joint range of motion decreased, Musculoskeletal pain
Clinical narrative: This is spontaneous case, reported by other non-health professional to VAERS and initially retrieved on 21-Feb-2018 by Seqirus from VAERS (VAERS ID: 728847), concerns a 37-year-old, adult female patient. The patient's medical history was not reported. The patient's concomitant medications included Oral contraceptive, LEXAPRO (as reported). On 26-Oct-2017, the patient received AFLURIA QUADRIVALENT (dose: 0.5 ml, anatomical location: left arm, route of administration: intramuscular, batch number and expiry date: not reported). On the same day, immediately after receiving the flu shot the patient had pain, burning sensation and irritability. The pain eventually reduced, but not entirely. It was reported that, the patient had soreness and pain in shoulder and arm. Pain increased as time when on (as reported) and then it was worst. It was stated that, the pain started in shoulder, radiating down the arm. The patient's range of motion decreased that she cannot raise arm, but can put pressure on her elbow. The patient's daily movements were painful, even while putting a coat or sweater on. The pain was constant, even though it has been a month since she received shot. The overall pain increased as well as immobility. It was reported that, the patient did undergo any laboratory investigations as she thought it was a muscle pain. At the time of this report, the patient had not yet recovered from the events. The reporter assessed the case as non-serious.
Age: 37.0
Sex: F
Vaccine: FLU4
Symptoms: Pain, Pain in extremity
Clinical narrative: This is spontaneous case, reported by other non-health professional to VAERS and initially retrieved on 21-Feb-2018 by Seqirus from VAERS (VAERS ID: 728847), concerns a 37-year-old, adult female patient. The patient's medical history was not reported. The patient's concomitant medications included Oral contraceptive, LEXAPRO (as reported). On 26-Oct-2017, the patient received AFLURIA QUADRIVALENT (dose: 0.5 ml, anatomical location: left arm, route of administration: intramuscular, batch number and expiry date: not reported). On the same day, immediately after receiving the flu shot the patient had pain, burning sensation and irritability. The pain eventually reduced, but not entirely. It was reported that, the patient had soreness and pain in shoulder and arm. Pain increased as time when on (as reported) and then it was worst. It was stated that, the pain started in shoulder, radiating down the arm. The patient's range of motion decreased that she cannot raise arm, but can put pressure on her elbow. The patient's daily movements were painful, even while putting a coat or sweater on. The pain was constant, even though it has been a month since she received shot. The overall pain increased as well as immobility. It was reported that, the patient did undergo any laboratory investigations as she thought it was a muscle pain. At the time of this report, the patient had not yet recovered from the events. The reporter assessed the case as non-serious.
Age: 77.0
Sex: M
Vaccine: FLU4, PPV
Symptoms: Discomfort, Injection site discomfort, Injection site erythema, Injection site swelling, Limb discomfort
Clinical narrative: This is spontaneous case, reported by other non-health professional to VAERS and initially retrieved on 21-Feb-2018 by Seqirus from VAERS (VAERS ID: 728968), concerns a 77-year-old, elderly male patient. The patient's current condition included diabetic 2 (as reported). The patient's historical conditions included lung cancer (in remission 22-Sep-2015), Baroreflex autonomic syndrome. The patient's historical drugs included aspirin (80 mg) and amiodarone. On 29-Nov-2017, the patient received AFLURIA QUADRIVALENT (dose: 0.5 ml, batch number: XF30907, anatomical location: left arm, route of administration: intramuscular). On 29-Nov-2017, the patient received co-suspect PNEUMOVAX (dose: unknown, batch number: N024384, anatomical location: left arm, route of administration: not reported). On the same day, at 6:00 PM, the patient experienced discomfort, by 9:00 PM the patient had pain in his left arm (scale 1-10 was a 13-15 as reported). It was reported that, the pain was worse that he ever had in 77 years. Two days later, quite a bit of discomfort and swelling from his left shoulder down the arm within 5 inches from the wrist was noted. It was reported that, the patient had a considerable amount of redness on the site of swelling. It was reported that, the patient did not undergo any laboratory investigations, but the events were witnessed by the PCP (physician) (on 30-Nov-2017, at 12:30 PM). At the time of this report, the patient had not yet recovered from the events. The reporter assessed the case as non-serious. Non-significant case correction received with IRD 21-Feb-2018: Case comment was updated.
Age: 77.0
Sex: M
Vaccine: FLU4, PPV
Symptoms: Pain in extremity, Peripheral swelling
Clinical narrative: This is spontaneous case, reported by other non-health professional to VAERS and initially retrieved on 21-Feb-2018 by Seqirus from VAERS (VAERS ID: 728968), concerns a 77-year-old, elderly male patient. The patient's current condition included diabetic 2 (as reported). The patient's historical conditions included lung cancer (in remission 22-Sep-2015), Baroreflex autonomic syndrome. The patient's historical drugs included aspirin (80 mg) and amiodarone. On 29-Nov-2017, the patient received AFLURIA QUADRIVALENT (dose: 0.5 ml, batch number: XF30907, anatomical location: left arm, route of administration: intramuscular). On 29-Nov-2017, the patient received co-suspect PNEUMOVAX (dose: unknown, batch number: N024384, anatomical location: left arm, route of administration: not reported). On the same day, at 6:00 PM, the patient experienced discomfort, by 9:00 PM the patient had pain in his left arm (scale 1-10 was a 13-15 as reported). It was reported that, the pain was worse that he ever had in 77 years. Two days later, quite a bit of discomfort and swelling from his left shoulder down the arm within 5 inches from the wrist was noted. It was reported that, the patient had a considerable amount of redness on the site of swelling. It was reported that, the patient did not undergo any laboratory investigations, but the events were witnessed by the PCP (physician) (on 30-Nov-2017, at 12:30 PM). At the time of this report, the patient had not yet recovered from the events. The reporter assessed the case as non-serious. Non-significant case correction received with IRD 21-Feb-2018: Case comment was updated.
Sex: M
Vaccine: FLU4
Symptoms: Alcohol use disorder, Drooling, Eructation, Negativism, Skin discolouration
Clinical narrative: This spontaneous case, reported by other health professional to VAERS and initially retrieved on 21-Feb-2018 by Seqirus from VAERS (VAERS ID: 728969), concerning a 69-year-old, elderly male patient. The patient's medical history and current condition was not reported. On 31-Oct-2017, the patient was received AFLURIA QUADRIVALENT (dose: 0.5 ml, route of administration: intramuscular, anatomical location, batch number and expiry date: not reported). On 01-Nov-2017, the patient experienced drooling, belching, green skin discoloration and vinegar based smell. The patient also had excessive alcohol intake and nihilism (negativism). The patient had recovered from the events excessive drooling, belching, green skin discoloration and vinegar based smell, excessive alcohol intake and nihilism. The reporter assessed the event as non-serious.
Sex: M
Vaccine: FLU4
Symptoms: Skin odour abnormal
Clinical narrative: This spontaneous case, reported by other health professional to VAERS and initially retrieved on 21-Feb-2018 by Seqirus from VAERS (VAERS ID: 728969), concerning a 69-year-old, elderly male patient. The patient's medical history and current condition was not reported. On 31-Oct-2017, the patient was received AFLURIA QUADRIVALENT (dose: 0.5 ml, route of administration: intramuscular, anatomical location, batch number and expiry date: not reported). On 01-Nov-2017, the patient experienced drooling, belching, green skin discoloration and vinegar based smell. The patient also had excessive alcohol intake and nihilism (negativism). The patient had recovered from the events excessive drooling, belching, green skin discoloration and vinegar based smell, excessive alcohol intake and nihilism. The reporter assessed the event as non-serious.
Sex: F
Vaccine: FLU4
Symptoms: Eye irritation, Eye pruritus, Injection site pruritus, Nasal discomfort, Nasal pruritus
Clinical narrative: This spontaneous case, reported by non-healthcare professional to VAERS and initially retrieved on 21-Feb-2018 by Seqirus from VAERS (VAERS ID: 728974), concerns a 45-year-old, adult female patient. The patient's history included Lupus. On 31-Nov-2017, the patient was administered with AFLURIA QUADRIVALENT (dose: 0.5 ml (reported as 1), route of administration: intramuscular, anatomical location: left arm, batch number: XF31307, expiry date: not reported). Initially after vaccination, the patient had itching at the site of vaccination. Approximately after 2 hours of vaccination, the patient developed itching and burning of eyes and nose. The patient visited the physician's office for consultation. The vitals signs monitored were temperature (T) 97.9, pulse: 82, respiratory rate: 16, blood pressure: 126/73, pulse oximetry: 100 percent. No labs were collected (as reported). At the time of this report, the patient had recovered from the events (itching at the site of vaccination, itching and burning of eyes and nose). The reporter assessed the case as non-serious.
Sex: M
Vaccine: FLU4
Symptoms: Musculoskeletal pain, Pain in extremity
Clinical narrative: This spontaneous case, reported by non-health care professional (other) to VAERS and initially retrieved on 21-Feb-2018 by Seqirus from VAERS (VAERS ID: 729145), concerns a 63-year-old, adult, male patient. The patient's historical condition included musculoskeletal pain, pain in extremity, stomach sensitivity (on an unspecified date in past). The current condition included allergy to fish since young. The patient had no concomitant medications. On 31-Oct-2017, the patient was administered with AFLURIA QUADRIVALENT (dose: 0.5 ml, route of administration: injection, anatomical location: right arm, batch number and expiry date: not reported). On the same day, after vaccination, the patient had sharp pain in the shoulder, down to his arm. The patient was recommended to consult with an orthopaedic on unspecified date in Nov-2014 and no tests were recommended, the patient was treated with Ibuprofen as 4 per day. Later, the patient had second visit to orthopaedic for further follow-up. At the time of the report, the patient had not recovered from the events (pain in arm and shoulder pain). The reporter assessed the events as non-serious and causality as related to the suspect vaccine. Non-significant case correction received with IRD 21-Feb-2018: Narrative was corrected.
Age: 50.0
Sex: F
Vaccine: FLU4
Symptoms: Diarrhoea, Headache, Peripheral swelling, Pyrexia, Vomiting
Clinical narrative: This spontaneous case, reported by other health professional to VAERS and initially retrieved on 21-Feb-2018 by Seqirus from VAERS (VAERS ID: 729176), concerning a 50-year-old, adult female patient. The patient's historical condition included: psoriatic arthritis and had reactions of arm swelling and mild fever to unspecified vaccines. The patient was allergic to milk, eggs, gluten, latex, IMITREX and NEURONTIN. Current condition included: systemic lupus erythematosus. Concomitant medications included: PLAQUENIL, levothyroxine, estradiol, progesterone, prednisone, citalopram, ARAVA. On 29-Nov-2017, the patient was administered with AFLURIA QUADRIVALENT (dose: 0.5 ml (reported as 1 dose), route of administration: injection (reported as SYR), anatomical location: right arm, batch number, expiry date: not reported). On the same day, after vaccination, the patient developed swollen arm, mild fever from 29-Nov-2017 to 01-Dec-2017 followed by vomiting, diarrhea, severe headache and fever of 99 to 103.7. The patient had recovered from all the events. The reporter assessed the case as non-serious.
Age: 40.0
Sex: F
Vaccine: FLU4
Symptoms: Oral mucosal eruption
Clinical narrative: This spontaneous case, reported by other health professional to VAERS and initially retrieved on 21-Feb-2018 by Seqirus from VAERS (VAERS ID: 729287), concerning a 40-year-old, adult female patient. The patient's current condition included: hypertension, osteoarthritis, hyperlipidemia, asthma and bronchitis. Concomitant medications included: Amlodipine, HCTZ, Lovastatin, Vitamin D and Meloxicam for an unknown indication. On 13-Nov-2017, the patient was administered with AFLURIA QUADRIVALENT (dose: 0.5 ml, route of administration: intramuscular, anatomical location: left arm, batch number: XF34409, expiry date: not reported). On an unspecified date in Nov-2017 (reported as Nov-2019), the patient received non-company suspect drug (FLUZONE QUAD) for influenza immunization with no complication. On the same day (13-Nov-2017), approximately after 30 to 40 minutes of vaccination, the patient developed bumps and rash around her mouth. Hence, she made a visit to her physician for the events. The patient was given diphenhydramine (dose: 25 mg via intramuscular route). The patient completely recovered from the event on the same day (13-Nov-2017) and no other symptoms were reported. The report assessed the event as non-serious. Significant case correction received with IRD 21-Feb-2018: The causality of the event bumps and rash around her mouth was changed from not related to related. Case comment was amended accordingly.
Sex: M
Vaccine: DTAPHEPBIP, FLU4, MNQ
Symptoms: Diarrhoea, Malaise, Pyrexia, Vomiting
Clinical narrative: This spontaneous case, reported by Non-health care professional (other) to VAERS and initially retrieved on 21-Feb-2018 by Seqirus from VAERS (VAERS ID: 729381), concerns a 6-month-old infant male patient. On 30-Nov-2017, the patient was administered with AFLURIA QUADRIVALENT (dose: 0.5ml, route of administration: injection, anatomical location: left leg, batch number and expiry date: not reported). On the same day, the patient was administered with PEDIARIX (route of administration: injection, anatomical location: left leg, dose, batch number and expiry date: not reported) and MENACTRA (route of administration: injection, anatomical location: left leg, dose, batch number and expiry date: not reported). On 01-Dec-2017, 2 days after vaccination, the patient felt sick and experienced 101.2 fever. On the next day, the patient started to throw up so badly (as reported), hence the patient was taken to the emergency room. The patient was treated with ZOFRAN, so that he can hold down even a couple ounces of breast milk. The patient experienced diarrhoea. The treating doctor was discredited that, it was reaction to the vaccine and it must be due to the vaccine. The patient's mother stated that, the reaction was due to the vaccine. The outcome of the events was unknown. The reporter assessed this case as non-serious. Non-significant case correction received with IRD 21-Feb-2018: The narrative statement was corrected.
Age: 67.0
Sex: F
Vaccine: FLU4
Symptoms: Abdominal pain upper, Choking, Cough, Fatigue, Feeling abnormal
Clinical narrative: This is spontaneous case, reported by other health professional to VAERS and initially retrieved on 21-Feb-2018 by Seqirus from VAERS (VAERS ID: 729411), concerns a 67-year-old, elderly female patient. The patient's historical condition included depression. The patient's concomitant medications included calcium, vitamin D, ranitidine and AZULFADINE. The patient's current conditions included ulcerative colitis and osteoarthritis of knees, hips, shoulders, neck and spine. On 27-Nov-2017, the patient received AFLURIA QUADRIVALENT (dose: 0.5 ml, batch number: XF31808, anatomical location: left arm, route of administration: intramuscular). On 28-Nov-2017, the patient experienced coughing to a point of choking. The patient had stomach pain, urination, fatigue, runny nose and her eyes became red. The patient felt poor (poorly as reported) as she missed work on 30-Nov-2017, and went to ER (emergency room). It was reported that the patient also missed work on 01-Dec-2017. On the same day, the patient had influenza test which found to be negative for both influenza A and B. The patient was at work on 04-Dec-2017. At the time of report, the patient recovered from the events. The reporter assessed the case as non-serious. Significant case correction received with the IRD 21-Feb-2018: The causality for the events stomach pain and choking was corrected from related to unassessable. The verbatim for the event impaired to work ability was corrected. Current condition ulcerative colitis was added in case comment.
Age: 67.0
Sex: F
Vaccine: FLU4
Symptoms: Impaired work ability, Influenza A virus test negative, Influenza B virus test, Influenza virus test negative, Ocular hyperaemia
Clinical narrative: This is spontaneous case, reported by other health professional to VAERS and initially retrieved on 21-Feb-2018 by Seqirus from VAERS (VAERS ID: 729411), concerns a 67-year-old, elderly female patient. The patient's historical condition included depression. The patient's concomitant medications included calcium, vitamin D, ranitidine and AZULFADINE. The patient's current conditions included ulcerative colitis and osteoarthritis of knees, hips, shoulders, neck and spine. On 27-Nov-2017, the patient received AFLURIA QUADRIVALENT (dose: 0.5 ml, batch number: XF31808, anatomical location: left arm, route of administration: intramuscular). On 28-Nov-2017, the patient experienced coughing to a point of choking. The patient had stomach pain, urination, fatigue, runny nose and her eyes became red. The patient felt poor (poorly as reported) as she missed work on 30-Nov-2017, and went to ER (emergency room). It was reported that the patient also missed work on 01-Dec-2017. On the same day, the patient had influenza test which found to be negative for both influenza A and B. The patient was at work on 04-Dec-2017. At the time of report, the patient recovered from the events. The reporter assessed the case as non-serious. Significant case correction received with the IRD 21-Feb-2018: The causality for the events stomach pain and choking was corrected from related to unassessable. The verbatim for the event impaired to work ability was corrected. Current condition ulcerative colitis was added in case comment.
Age: 67.0
Sex: F
Vaccine: FLU4
Symptoms: Rhinorrhoea
Clinical narrative: This is spontaneous case, reported by other health professional to VAERS and initially retrieved on 21-Feb-2018 by Seqirus from VAERS (VAERS ID: 729411), concerns a 67-year-old, elderly female patient. The patient's historical condition included depression. The patient's concomitant medications included calcium, vitamin D, ranitidine and AZULFADINE. The patient's current conditions included ulcerative colitis and osteoarthritis of knees, hips, shoulders, neck and spine. On 27-Nov-2017, the patient received AFLURIA QUADRIVALENT (dose: 0.5 ml, batch number: XF31808, anatomical location: left arm, route of administration: intramuscular). On 28-Nov-2017, the patient experienced coughing to a point of choking. The patient had stomach pain, urination, fatigue, runny nose and her eyes became red. The patient felt poor (poorly as reported) as she missed work on 30-Nov-2017, and went to ER (emergency room). It was reported that the patient also missed work on 01-Dec-2017. On the same day, the patient had influenza test which found to be negative for both influenza A and B. The patient was at work on 04-Dec-2017. At the time of report, the patient recovered from the events. The reporter assessed the case as non-serious. Significant case correction received with the IRD 21-Feb-2018: The causality for the events stomach pain and choking was corrected from related to unassessable. The verbatim for the event impaired to work ability was corrected. Current condition ulcerative colitis was added in case comment.
Sex: F
Vaccine: FLU4, PPV
Symptoms: Injected limb mobility decreased, Injection site reaction, Pain in extremity, Rash macular
Clinical narrative: This spontaneous case, reported by other health professional to VAERS and initially retrieved on 21-Feb-2018 by Seqirus from VAERS (VAERS ID: 729504), concerning a 79-year-old, elderly female patient. On 27-Oct-2016, the patient was administered with PREVNAR 13 and experienced extremely sore arm or lame arm. The patient had no current illness. The patient was allergic to penicillin and sulfa drug. Concomitant medications included: Verapamil, Omeprazole, Lisinopril and Lopemide. It was reported that, the patient did not have any extreme soreness or lame arm with PREVNAR. Hence, she chose to get PNEUMOVAX in non-dominant arm. On 29-Nov-2017, the patient was administered with AFLURIA QUADRIVALENT (dose: 0.5 ml, route of administration: intramuscular, anatomical location: right arm, batch number: XF30707, expiry date: not reported). On the same day, the patient also received non-company suspect drug PNEUMOVAX (2 doses (as reported), route of administration: intramuscular, anatomical location: left arm, batch number:N012127, expiry date: not reported). After administration of PREVNAR 13, the patient's left arm was very sore so had chosen to get the PNEUMOVAX 23 in her non-dominant arm in case she had a similar reaction. Hence, she took PNEUMOVAX 23 and experienced extremely sore arm and was unable to move her arm. She also noted red blotches on her upper arm. It was reported that, the patient did not seek any treatment. The patient had recovered from all the events. The reporter assessed the case as non-serious.
Age: 42.0
Sex: M
Vaccine: FLU4
Symptoms: Flushing, Nausea, Pain, Vomiting
Clinical narrative: This spontaneous case, reported by other health professional to VAERS and initially retrieved on 21-Feb-2018 by Seqirus from VAERS (VAERS ID: 729648), concerning a 42-year-old, adult, male patient. The patient had no medical history and current illness. The patient did not receive any concomitant medications. On 05-Dec-2017, the patient was administered with AFLURIA QUADRIVALENT (dose: 0.5 ml, route of administration: intramuscular, anatomical location: left arm, batch number: XF34509, expiry date: not reported). On the same day, one hour later, the patient developed nausea with vomiting. In addition, he also had flushed face, body aches and nausea. At the time of this report, the outcome of the events was unknown. The reporter assessed the events as non-serious.
Age: 39.0
Sex: F
Vaccine: FLU4
Symptoms: Injection site indentation
Clinical narrative: This spontaneous case, reported by other health professional to VAERS and initially retrieved on 21-Feb-2018 by Seqirus from VAERS (VAERS ID: 729679), concerning a 39-year-old, adult female patient. The patient's medical history and concomitant medications were not reported. On 27-Oct-2017, the patient was administered with AFLURIA QUADRIVALENT (dose: 0.5 ml (reported as 1 dose), route of administration: intramuscular, anatomical location: left arm, batch number: XF34609, expiry date: not reported). On 05-Dec-2017, after 1 month 9 days of vaccination, the patient developed an indention on her left deltoid area which measured 1 X 1.5 cm (10 x 15 mm). She believed that, it was present after influenza immunization where she received her flu vaccine. It was reported that, the patient made a visit to the physician for the events. However, she denied of any muscular issues or ROM (range of motion) deficiencies. No discoloration or bruising was noted to the area. The patient had recovered from all the events. The reporter assessed the events as non-serious. Significant case correction received with IRD 21-Feb-2018: Causality was changed from not related to related. Case comment was corrected.
Age: 59.0
Sex: F
Vaccine: FLU4, PPV
Symptoms: Arthralgia, Breast pain, Breast swelling, Breast tenderness, Chest discomfort
Clinical narrative: This spontaneous case, reported by other healthcare professional to VAERS and initially retrieved on 21-Feb-2018 by Seqirus from VAERS (VAERS ID: 729696), concerns a 59-year-old, adult female patient. The patient's historical conditions included chronic kidney disease, hyperlipidaemia. The patient's current condition included asthma and allergy to phenobarbital. The patient's concomitant medication included VENTOLIN, Milk thistle, 5-HTP tryptophan, Ca-Mg vit D and fish oil for unknown indication. On 30-Nov-2017, the patient was administered with AFLURIA QUADRIVALENT (dose: 0.5 ml (1 as reported), batch number: XF33208, anatomical location: left arm, route of administration: intramuscular and expiry date: not reported). On 30-Nov-2017, the patient was administered with PNEUMOVAX (dose: 1 DF, batch number: N029303, anatomical location: left arm, route of administration: intramuscular and expiry date: not reported). On the same day of vaccine administration, the patient had fever for 101 F for 3 days. The patient developed severe muscle aches mostly on left side, joint pain in the left hip, fatigue, tightness in chest toward left side, cough, hoarseness in voice, ear pain, headache, nausea and anorexia but no diarrhoea and difficulty swallowing. Some light-headedness was reported, but no syncope. The patient also had some light and sound sensitivity. It was stated that, the patient developed welts and rash at injection site, the rash spread to armpit about the size of a melon, but decreased on that day. She noted swollen lymph nodes in the left axilla for about 2 days only, but not on the right side. The patient also had some left breast pain, tenderness and swelling but resolved. Cough, hoarseness persisted, but muscle ache and joint pain improved. However, the patient still had some pain in neck and head, but no fever. On an unspecified date, the patient had recovered from the events. The reporter assessed the case as non-serious. Significant case correction received with IRD 21-Feb-2018: The as determined causality of all the events was corrected from unassessable to related. The case comment was corrected accordingly.
Age: 59.0
Sex: F
Vaccine: FLU4, PPV
Symptoms: Cough, Decreased appetite, Dizziness, Dysphonia, Ear pain
Clinical narrative: This spontaneous case, reported by other healthcare professional to VAERS and initially retrieved on 21-Feb-2018 by Seqirus from VAERS (VAERS ID: 729696), concerns a 59-year-old, adult female patient. The patient's historical conditions included chronic kidney disease, hyperlipidaemia. The patient's current condition included asthma and allergy to phenobarbital. The patient's concomitant medication included VENTOLIN, Milk thistle, 5-HTP tryptophan, Ca-Mg vit D and fish oil for unknown indication. On 30-Nov-2017, the patient was administered with AFLURIA QUADRIVALENT (dose: 0.5 ml (1 as reported), batch number: XF33208, anatomical location: left arm, route of administration: intramuscular and expiry date: not reported). On 30-Nov-2017, the patient was administered with PNEUMOVAX (dose: 1 DF, batch number: N029303, anatomical location: left arm, route of administration: intramuscular and expiry date: not reported). On the same day of vaccine administration, the patient had fever for 101 F for 3 days. The patient developed severe muscle aches mostly on left side, joint pain in the left hip, fatigue, tightness in chest toward left side, cough, hoarseness in voice, ear pain, headache, nausea and anorexia but no diarrhoea and difficulty swallowing. Some light-headedness was reported, but no syncope. The patient also had some light and sound sensitivity. It was stated that, the patient developed welts and rash at injection site, the rash spread to armpit about the size of a melon, but decreased on that day. She noted swollen lymph nodes in the left axilla for about 2 days only, but not on the right side. The patient also had some left breast pain, tenderness and swelling but resolved. Cough, hoarseness persisted, but muscle ache and joint pain improved. However, the patient still had some pain in neck and head, but no fever. On an unspecified date, the patient had recovered from the events. The reporter assessed the case as non-serious. Significant case correction received with IRD 21-Feb-2018: The as determined causality of all the events was corrected from unassessable to related. The case comment was corrected accordingly.
Age: 59.0
Sex: F
Vaccine: FLU4, PPV
Symptoms: Fatigue, Headache, Hyperacusis, Injection site rash, Lymphadenopathy
Clinical narrative: This spontaneous case, reported by other healthcare professional to VAERS and initially retrieved on 21-Feb-2018 by Seqirus from VAERS (VAERS ID: 729696), concerns a 59-year-old, adult female patient. The patient's historical conditions included chronic kidney disease, hyperlipidaemia. The patient's current condition included asthma and allergy to phenobarbital. The patient's concomitant medication included VENTOLIN, Milk thistle, 5-HTP tryptophan, Ca-Mg vit D and fish oil for unknown indication. On 30-Nov-2017, the patient was administered with AFLURIA QUADRIVALENT (dose: 0.5 ml (1 as reported), batch number: XF33208, anatomical location: left arm, route of administration: intramuscular and expiry date: not reported). On 30-Nov-2017, the patient was administered with PNEUMOVAX (dose: 1 DF, batch number: N029303, anatomical location: left arm, route of administration: intramuscular and expiry date: not reported). On the same day of vaccine administration, the patient had fever for 101 F for 3 days. The patient developed severe muscle aches mostly on left side, joint pain in the left hip, fatigue, tightness in chest toward left side, cough, hoarseness in voice, ear pain, headache, nausea and anorexia but no diarrhoea and difficulty swallowing. Some light-headedness was reported, but no syncope. The patient also had some light and sound sensitivity. It was stated that, the patient developed welts and rash at injection site, the rash spread to armpit about the size of a melon, but decreased on that day. She noted swollen lymph nodes in the left axilla for about 2 days only, but not on the right side. The patient also had some left breast pain, tenderness and swelling but resolved. Cough, hoarseness persisted, but muscle ache and joint pain improved. However, the patient still had some pain in neck and head, but no fever. On an unspecified date, the patient had recovered from the events. The reporter assessed the case as non-serious. Significant case correction received with IRD 21-Feb-2018: The as determined causality of all the events was corrected from unassessable to related. The case comment was corrected accordingly.
Age: 59.0
Sex: F
Vaccine: FLU4, PPV
Symptoms: Myalgia, Nausea, Neck pain, Photophobia, Pyrexia
Clinical narrative: This spontaneous case, reported by other healthcare professional to VAERS and initially retrieved on 21-Feb-2018 by Seqirus from VAERS (VAERS ID: 729696), concerns a 59-year-old, adult female patient. The patient's historical conditions included chronic kidney disease, hyperlipidaemia. The patient's current condition included asthma and allergy to phenobarbital. The patient's concomitant medication included VENTOLIN, Milk thistle, 5-HTP tryptophan, Ca-Mg vit D and fish oil for unknown indication. On 30-Nov-2017, the patient was administered with AFLURIA QUADRIVALENT (dose: 0.5 ml (1 as reported), batch number: XF33208, anatomical location: left arm, route of administration: intramuscular and expiry date: not reported). On 30-Nov-2017, the patient was administered with PNEUMOVAX (dose: 1 DF, batch number: N029303, anatomical location: left arm, route of administration: intramuscular and expiry date: not reported). On the same day of vaccine administration, the patient had fever for 101 F for 3 days. The patient developed severe muscle aches mostly on left side, joint pain in the left hip, fatigue, tightness in chest toward left side, cough, hoarseness in voice, ear pain, headache, nausea and anorexia but no diarrhoea and difficulty swallowing. Some light-headedness was reported, but no syncope. The patient also had some light and sound sensitivity. It was stated that, the patient developed welts and rash at injection site, the rash spread to armpit about the size of a melon, but decreased on that day. She noted swollen lymph nodes in the left axilla for about 2 days only, but not on the right side. The patient also had some left breast pain, tenderness and swelling but resolved. Cough, hoarseness persisted, but muscle ache and joint pain improved. However, the patient still had some pain in neck and head, but no fever. On an unspecified date, the patient had recovered from the events. The reporter assessed the case as non-serious. Significant case correction received with IRD 21-Feb-2018: The as determined causality of all the events was corrected from unassessable to related. The case comment was corrected accordingly.
Age: 59.0
Sex: F
Vaccine: FLU4, PPV
Symptoms: Urticaria
Clinical narrative: This spontaneous case, reported by other healthcare professional to VAERS and initially retrieved on 21-Feb-2018 by Seqirus from VAERS (VAERS ID: 729696), concerns a 59-year-old, adult female patient. The patient's historical conditions included chronic kidney disease, hyperlipidaemia. The patient's current condition included asthma and allergy to phenobarbital. The patient's concomitant medication included VENTOLIN, Milk thistle, 5-HTP tryptophan, Ca-Mg vit D and fish oil for unknown indication. On 30-Nov-2017, the patient was administered with AFLURIA QUADRIVALENT (dose: 0.5 ml (1 as reported), batch number: XF33208, anatomical location: left arm, route of administration: intramuscular and expiry date: not reported). On 30-Nov-2017, the patient was administered with PNEUMOVAX (dose: 1 DF, batch number: N029303, anatomical location: left arm, route of administration: intramuscular and expiry date: not reported). On the same day of vaccine administration, the patient had fever for 101 F for 3 days. The patient developed severe muscle aches mostly on left side, joint pain in the left hip, fatigue, tightness in chest toward left side, cough, hoarseness in voice, ear pain, headache, nausea and anorexia but no diarrhoea and difficulty swallowing. Some light-headedness was reported, but no syncope. The patient also had some light and sound sensitivity. It was stated that, the patient developed welts and rash at injection site, the rash spread to armpit about the size of a melon, but decreased on that day. She noted swollen lymph nodes in the left axilla for about 2 days only, but not on the right side. The patient also had some left breast pain, tenderness and swelling but resolved. Cough, hoarseness persisted, but muscle ache and joint pain improved. However, the patient still had some pain in neck and head, but no fever. On an unspecified date, the patient had recovered from the events. The reporter assessed the case as non-serious. Significant case correction received with IRD 21-Feb-2018: The as determined causality of all the events was corrected from unassessable to related. The case comment was corrected accordingly.
Sex: F
Vaccine: FLU4
Symptoms: Dizziness, Hyperhidrosis, Loss of consciousness, Nausea, Pallor
Clinical narrative: This spontaneous case, reported by health care professional (other) to VAERS and initially retrieved on 21-Feb-2018 by Seqirus from VAERS (VAERS ID: 729921), concerns a 25-year-old, adult, female patient. On an unspecified date, as the patient was child, she had similar reaction, fainted upon blood withdrawal. The patient had no concomitant medications. On 07-Dec-2017, the patient was administered with AFLURIA QUADRIVALENT (dose: 0.5 ml (1 as reported), route of administration: intramuscular, anatomical location: left arm, batch number XT32008 and expiry date: not reported). On the same day, after vaccination, the patient was pale and experienced nausea, vomiting, dizzy and sweating. It was reported that, the patient also had slight loss of consciousness. Later, patient was given water, ginger ale and became normal. The patient monitored for 15 minutes for any side effects. The patient felt better after vomiting and drinking ginger ale. At the time of the report, the patient had recovered from the events (dizziness, sweating, loss of consciousness, pale, nausea and vomiting). The reporter assessed the case as non-serious.
Sex: F
Vaccine: FLU4
Symptoms: Vomiting
Clinical narrative: This spontaneous case, reported by health care professional (other) to VAERS and initially retrieved on 21-Feb-2018 by Seqirus from VAERS (VAERS ID: 729921), concerns a 25-year-old, adult, female patient. On an unspecified date, as the patient was child, she had similar reaction, fainted upon blood withdrawal. The patient had no concomitant medications. On 07-Dec-2017, the patient was administered with AFLURIA QUADRIVALENT (dose: 0.5 ml (1 as reported), route of administration: intramuscular, anatomical location: left arm, batch number XT32008 and expiry date: not reported). On the same day, after vaccination, the patient was pale and experienced nausea, vomiting, dizzy and sweating. It was reported that, the patient also had slight loss of consciousness. Later, patient was given water, ginger ale and became normal. The patient monitored for 15 minutes for any side effects. The patient felt better after vomiting and drinking ginger ale. At the time of the report, the patient had recovered from the events (dizziness, sweating, loss of consciousness, pale, nausea and vomiting). The reporter assessed the case as non-serious.
Age: 62.0
Sex: F
Vaccine: FLU4
Symptoms: Dizziness, Feeling abnormal, Paraesthesia, Stress
Clinical narrative: This spontaneous case, reported by other healthcare professional to VAERS and initially retrieved on 21-Feb-2018 by Seqirus from VAERS (VAERS ID: 729981), concerns a 62-year-old, adult female patient. The patient had no current illness at the time of vaccination. On 08-Dec-2017, the patient was administered with AFLURIA QUADRIVALENT (dose: 0.5 ml, route of administration: intramuscular, anatomical location, batch number, expiry date: not reported). On the same day, the patient had a tingling sensation that moved up her body, light-headedness and felt weird. The patient's blood pressure approximately after 20 minutes of vaccination was found to 129/92, 20 minutes later, the blood pressure was found to be 135/85 and again 20 minutes later, the blood pressure was found to be 131/85. The patient had recovered from the events (normal) after 2 hours. It was reported that the patient was very stressed due to upcoming trip (as reported). The reporter assessed the case as non-serious. Non-significant case correction received with IRD 21-Feb-2018: The sentence (The patient's blood pressure approximately after 20 minutes of vaccination was found to 129/92, 20 minutes later, the blood pressure was found to be 138/85 and again 20 minutes later, the blood pressure was found to be 131/85) was referred.